Haematological disorders require specialist haematology input, with treatment tailored to the specific diagnosisranging from observation to chemotherapy for malignant conditions
Compounded Tirzepatide with B12: What to Know Before You Start Last Updated May 2026 If you have spent time scrolling through weight loss options lately, you have probably come across tirzepatide, GLP-1, or compounded medical weight loss
BPC-157 provides vascular support for nutrient delivery to wound sites
AOD 9604 clinical trials The early data looked promising
Retatrutide is an investigational triple hormone agonist (GLP-1, GIP, glucagon) showing promising early results for obesity and type 2 diabetes, while tirzepatide is an FDA-approved dual agonist (GLP-1, GIP) available for use today
A negative PCAC outcome today leaves that market intact as the only practical access point for these compounds